![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 237/32 | |
C07D 403/06 | |||
C07D 403/04 | |||
C07D 403/14 | |||
A61K 31/502 | |||
A61P 29/00 | |||
A61P 37/08 |
(11) | Patento numeris | 2007735 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 07728235.8 |
Europos patento paraiškos padavimo data | 2007-04-18 | |
(97) | Europos patento paraiškos paskelbimo data | 2008-12-31 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2010-10-27 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2007/053773 |
Data | 2007-04-18 |
(87) | Numeris | WO 2007/122156 |
Data | 2007-11-01 |
(30) | Numeris | Data | Šalis |
0607839 | 2006-04-20 | GB | |
0706160 | 2007-03-29 | GB | |
0706176 | 2007-03-29 | GB |
(72) |
GORE, Paul, Martin, GB
HANCOCK, Ashley, Paul, GB
HODGSON, Simon, Teanby, GB
KINDON, Leanda, Jane, GB
PROCOPIOU, Panayiotis, Alexandrou, GB
|
(73) |
Glaxo Group Limited,
Glaxo Wellcome House Berkeley Avenue, Greenford Middlesex UB6 0NN,
GB
|
(54) | 2-SUBSTITUTED 4-BENZYLPHTHALAZINONE DERIVATIVES AS HISTAMINE H1 AND H3 ANTAGONISTS |
2-SUBSTITUTED 4-BENZYLPHTHALAZINONE DERIVATIVES AS HISTAMINE H1 AND H3 ANTAGONISTS |